Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Predicting Patient-Specific Radiosensitivity With Machine Learning and Genetic Profiling
FY 2023-24
Summary
Radiotherapy plays a therapeutic role in 40% of all cancer cures. However, patient heterogeneity with respect to radiosensitivity greatly impacts the effectiveness of radiotherapy treatment. The same amount of prescribed physical dose during treatment can yield different levels of normal tissue toxicity and tumor control in different patients. This project aims to address the existing challenges in personalized cancer treatment by combining machine learning and human genomics, specifically focusing on intrinsic radiosensitivity in head-and-neck and colorectal cancer patients. The complexity of genetic pathways makes it difficult to identify the leading-order effects of genomic profile in cancer radiosensitivity. Therefore, machine learning models trained on existing patient data offers a way to identify the relationships relevant to radiosensitivity within the genome. A growing amount of genomic data is becoming publicly available, opening new opportunities to train such algorithms successfully. If successful, this approach could help inform patient-specific treatment planning, paving the way for more effective and tailored cancer treatments.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506187
Name
Wadge Elliot
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Predicting Patient-Specific Radiosensitivity With Machine Learning and Genetic Profiling
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Artificial Intelligence; Colorectal Cancer; Genomics; Head And Neck Cancer; Machine Learning; Radiosensitivity; Radiotherapy
Abstract
Radiotherapy plays a therapeutic role in 40% of all cancer cures. However, patient heterogeneity with respect to radiosensitivity greatly impacts the effectiveness of radiotherapy treatment. The same amount of prescribed physical dose during treatment can yield different levels of normal tissue toxicity and tumor control in different patients. This project aims to address the existing challenges in personalized cancer treatment by combining machine learning and human genomics, specifically focusing on intrinsic radiosensitivity in head-and-neck and colorectal cancer patients. The complexity of genetic pathways makes it difficult to identify the leading-order effects of genomic profile in cancer radiosensitivity. Therefore, machine learning models trained on existing patient data offers a way to identify the relationships relevant to radiosensitivity within the genome. A growing amount of genomic data is becoming publicly available, opening new opportunities to train such algorithms successfully. If successful, this approach could help inform patient-specific treatment planning, paving the way for more effective and tailored cancer treatments.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wadge, Elliot
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~